Background Opioid use and opioid-related overdose continue to rise among racial/ethnic
minorities. Social determinants of health negatively impact these communities, possibly …

Background: Multiple studies in the National Institute on Drug Abuse Clinical Trials Network
(CTN) demonstrate strategies for conducting effective substance abuse treatment research …

Introduction Racial health inequities exist in the United States. Racial minorities and whites
have different health care experiences and health outcomes. Past studies examined this …

What accounts for variation across racial and ethnic groups in drug use and harms related to
substance use? While explanatory mechanisms for racial and ethnic disparities include …

Deliberate actions to promote racial and ethnic diversity among addiction researchers and
providers is increasingly being recognized as a necessary step in the effort to mitigate …

Structural racism,“the totality of ways in which societies foster racial discrimination through
mutually reinforcing systems of housing, education, employment, earnings, benefits, credit …

Introduction Historically, racial and ethnic minority populations have been underrepresented
in clinical research, and the recruitment and retention of women and ethnic minorities in …

Objective Racial/ethnic disparities in the use of substance abuse treatment services have
been documented. The objective of this study was to re-examine if racial/ethnic disparities in …

Objectives The aims of the study are to review the current research on the association
between access to medications for opioid use disorders (MOUD) and race, to identify gaps …

Underrepresentation in clinical trials limits the extent to which ethnic minorities benefit from
advances in substance abuse treatment. The objective of this article is to share the …